Learn / Stock guides / LLY vs REGN
CompareELI LILLY & Co vs Regeneron Pharmaceuticals: how do the stocks compare?
LLY and REGN side by side, in plain English. This is an explanation of the two businesses, not a recommendation to buy either one.
| LLY | REGN | |
|---|---|---|
| Ticker | LLY | REGN |
| Exchange | NYSE | NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers General | Biotechnology |
| Size | mega cap | large cap |
| Market value | 1.08 trillion dollars | 75.7 billion dollars |
ELI LILLY & Co (LLY)
ELI LILLY & Co trades on the New York Stock Exchange under the ticker LLY. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 1.08 trillion dollars.
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals trades on the Nasdaq under the ticker REGN. It is a large cap company in the biotechnology industry, part of the healthcare sector, with a market value of about 75.7 billion dollars.
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
Follow LLY and REGN every day
Add both to your watchlist and read a free plain English brief every trading day at 5 PM ET.
Start my free briefCommon questions
What is the difference between LLY and REGN?
ELI LILLY & Co trades on the New York Stock Exchange under the ticker LLY. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 1.08 trillion dollars. Regeneron Pharmaceuticals trades on the Nasdaq under the ticker REGN. It is a large cap company in the biotechnology industry, part of the healthcare sector, with a market value of about 75.7 billion dollars.
Which is bigger, ELI LILLY & Co or Regeneron Pharmaceuticals?
ELI LILLY & Co has the larger market value, at about 1.08 trillion dollars.
Are ELI LILLY & Co and Regeneron Pharmaceuticals in the same industry?
ELI LILLY & Co is in Drug Manufacturers General, while Regeneron Pharmaceuticals is in Biotechnology.
Educational information, not financial advice. Figures are approximate and do not include live prices.